Effective Preexposure Tuberculosis Vaccines Fail To Protect When They Are Given in an Immunotherapeutic Mode
- 1 March 2000
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (3) , 1706-1709
- https://doi.org/10.1128/iai.68.3.1706-1709.2000
Abstract
Two vaccine formulations previously shown to induce protective immunity in mice and prevention of long-term necrosis in guinea pigs were tested as potential immunotherapeutic vaccines in mice earlier infected by aerosol with Mycobacterium tuberculosis. Neither vaccine had any effect on the course of the infection in the lungs, but both reduced the bacterial load in the spleen. Similarly, inoculation with Mycobacterium bovis BCG had no effect whatsoever and, if given more than once, appeared to induce an increasingly severe pyogranulomatous response in the lungs of these mice.Keywords
This publication has 19 references indexed in Scilit:
- Cytokine/chemokine cascades in immunity to tuberculosisImmunology Today, 1999
- Therapy of tuberculosis in mice by DNA vaccinationNature, 1999
- NEW VACCINES AGAINST TUBERCULOSIS: The Status of Current ResearchInfectious Disease Clinics of North America, 1999
- Vaccination against Tuberculosis: Recent ProgressPublished by Elsevier ,1999
- Vaccines, Genes and TrialsPublished by Wiley ,1998
- The Role of TGFβ in the Pathogenesis of Human TuberculosisClinical Immunology and Immunopathology, 1998
- Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosisTubercle and Lung Disease, 1997
- Immunogenicity and protective efficacy of a tuberculosis DNA vaccineNature Medicine, 1996
- Tuberculosis in developing countries and methods for its controlTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- Antimycobacterial ActivityIn Vivoof LM427 (Rifabutin)American Review of Respiratory Disease, 1988